Candida albicans Endophthalmitis in Brown Heroin Addicts: Response to Early Vitrectomy Preceded and Followed by Antifungal Therapy

The management of Candida albicans endophthalmitis in intravenous drug abusers (IVDAs) has yet to be established. Early vitrectomy was previously reported as a promising treatment for C. albicans endophthalmitis. In our series, C. albicans endophthalmitis was diagnosed for 15 IVDAs. Funduscopic exam...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 27; no. 5; pp. 1130 - 1133
Main Authors Martínez-Váquez, C., Fernández-Ulloa, J., Bordón, J., Sopeña, B., de la Fuente, J., Ocampo, A., Rubianes, M.
Format Journal Article
LanguageEnglish
Published United States The University of Chicago Press 01.11.1998
University of Chicago Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The management of Candida albicans endophthalmitis in intravenous drug abusers (IVDAs) has yet to be established. Early vitrectomy was previously reported as a promising treatment for C. albicans endophthalmitis. In our series, C. albicans endophthalmitis was diagnosed for 15 IVDAs. Funduscopic examinations confirmed severe vitritis in 12 patients and chorioretinitis in three. Blood and vitreal cultures were positive for C. albicans for seven and eight patients, respectively. Patients with vitritis received antifungal therapy before and after vitrectomy. Amphotericin B or fluconazole therapy was given according to the physician's preference. Vitrectomy was defined as early if it was performed within 1 week after the diagnosis of vitritis. All seven patients who underwent early vitrectomy had a favorable response without complications. Two of three patients who underwent late vitrectomy developed blindness or scotoma. Blindness was also described in two patients with vitritis who did not undergo vitrectomy. Early vitrectomy preceded and followed by antifungal therapy seems to be appropriate management of vitritis in IVDAs.
Bibliography:ark:/67375/HXZ-4H46HPR4-0
istex:DE7A9C2CF1070A844DB97004D4288F3956B7F284
Reprints or correspondence: Dr. Jose Bordón, Department of Internal Medicine, Providence Hospital, 1150 Varnum Street, NE, Washington, DC 20017.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1058-4838
1537-6591
DOI:10.1086/514972